Verrica Pharmaceuticals Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · West Chester, PA
VRCA chart
What traders are saying about $VRCA
Latest postsVerrica Pharmaceuticals Inc. news
- Verrica Pharmaceuticals Inc. Estimates – NASDAQ:VRCA
TradingView ·
- Verrica Pharmaceuticals Inc. (1NE0.F) insider ownership and holdings
Yahoo Finance Australia ·
- Verrica Pharmaceuticals Announces Achievement of Milestones Unlocking Access to the Full $27.5 Million of Non-Dilutive Growth Capital Under Credit Facility
Yahoo Finance ·
- Verrica Pharmaceuticals to Present New YCANTH® Data Analysis at Two Upcoming Dermatology Conferences
Yahoo Finance ·
- Verrica Pharmaceuticals to Present YCANTH® and VP-315 Data at Two Upcoming Dermatology Conferences
Yahoo Finance ·
- Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- Verrica completes enrolment in Phase III trial of Ycanth
hospitalmanagement.net ·
- Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027
Yahoo Finance ·
- Verrica Pharmaceuticals Q2 Earnings Call Highlights
marketbeat.com ·
- Verrica Pharmaceuticals Inc. (VRCA) Reports Q2 Loss, Beats Revenue Estimates
Yahoo Finance ·
- Verrica Pharmaceuticals Reports Second Quarter 2026 Financial Results
Yahoo Finance ·
- Verrica Pharmaceuticals Closes Credit Facility For Up To $27.5 Million in Non-Dilutive Growth Capital
Yahoo Finance ·
Verrica Pharmaceuticals Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $7.6M | $5.1M | $9.0M |
| Net income | -$17.9M | -$76.6M | -$67.0M | -$24.5M |
| Diluted EPS | $-1.68 | $-14.78 | $-1.48 | $-0.72 |
| Total assets (year end) | $47.1M | $54.1M | $81.6M | $44.7M |
| Cash and equivalents (year end) | $30.1M | $46.3M | $69.5M | $34.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Verrica Pharmaceuticals Inc.
- Ticker
- VRCA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- West Chester, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1660334
Frequently asked questions
What exchange is Verrica Pharmaceuticals Inc. listed on?
Verrica Pharmaceuticals Inc. trades on the Nasdaq under the ticker symbol VRCA.
What industry is Verrica Pharmaceuticals Inc. in?
Verrica Pharmaceuticals Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Verrica Pharmaceuticals Inc. headquartered?
Verrica Pharmaceuticals Inc.'s business address on file with the SEC is in West Chester, PA.
When does Verrica Pharmaceuticals Inc.'s fiscal year end?
Verrica Pharmaceuticals Inc.'s fiscal year ends on December 31.
How much revenue did Verrica Pharmaceuticals Inc. report?
Verrica Pharmaceuticals Inc. reported $7.6M in revenue for calendar year 2024, according to its SEC filings.